/ /

Lynda Charters
Novel dry eye therapy shows increased efficacy, rapid onset of action
The efficacy of a novel dry eye therapeutic may bring a valuable addition to the dry eye armamentarium with a rapid onset of action and better patient tolerability.
New ocular allergy drug’s MOA targets inflammation
New ocular allergy drug’s MOA targets inflammation
A new, first-in-class, aldehyde-trap topical drop demonstrated rapid onset of action and sustained efficacy with an acceptable safety profile in a phase II clinical trial of patients with moderate-to-severe allergic conjunctivitis.
Why NAION remains an ophthalmologist’s dilemma
Why NAION remains an ophthalmologist’s dilemma
Though much has been learned about non-arteritic ischemic neuropathy since the earliest studies, no effective treatment is currently available. An update on research progress is highlighted.
Combination of NSAIDs and steroids reduces CME outcomes
A hot topic in cataract surgery is alternative ways to administer perioperative medications with the goal of lowering the incidence of cystoid macular edema (CME). One way to achieve that goal would be the combination of non-steroidal anti-inflammatory drugs (NSAIDs) and transzonular steroids.
Strabismus much more than orbital pulleys and muscles
New discoveries about extraocular muscles have widened the range of diagnoses and surgical techniques for strabismus.
Managing infections in artificial cornea
Managing infections in artificial cornea
Improvements in the Boston Keratoprosthesis device have resulted in fewer complications after implantation, but they still occur. Surgeons should be alert to development of infectious keratitis and endophthalmitis postoperatively.
How punctal plugs may influence tear osmolarity and aid in dry eye therapies
Tear osmolarity decreases with punctal plug insertion and serves as a leading indicator of therapeutic efficacy in dry eye disease.
How chronic pain syndromes and dry eye are correlated
There appears to be an association between chronic pain syndromes, mental health, and dry eye, which, according to the researchers who identified this link, might indicate a central pain disorder.
How new eye drop is stabilizing and relieving dry eye
A novel lubricant eye drop that specifically targets tear film evaporation in dry eye disease seems safe and effective for treating mild-to-moderate evaporative disease.
Two recent genetic discoveries may offer hope for patients with advanced AMD
The discovery of a gene for North Carolina macular dystrophy, PRDM13, and transplantation of induced pluripotent stem cells (iPSCs)-derived retinal cells show promise to restoring vision to patients with advanced AMD.


View Results